Hematology-Oncology Therapy, 3e (Feb 4, 2022)_(1260117405)_(McGraw Hill)

The essential therapy guide to cancer, hematologic disorders, and supportive care—updated with the latest treatment regimens Hematology-Oncology Therapy, Third Edition, is an up-to-date, comprehensive therapy guide that delivers more than 800 treatment regimens in a succinct, uniform format. Supported by the latest practice guidelines, peer-reviewed literature, and insights from experts in the field, this peerless resource integrates extensive information critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into four sections: Cancer Regimens: Covers administration, toxicity, dose modification, monitoring, supportive care, and the efficacy of commonly used and recently approved therapeutic regimens, and includes expert opinion and critical information on epidemiology, pathology, work-up, and staging, as well as survival data Antiemetics, Growth Factors, Dose Modification and Drug Preparation: Provides in-depth coverage of antiemetics, growth factors, and the administration and formulation of anti-cancer drugs Supportive Care, Complications, and Screening (online): Offers thorough coverage of topics commonly encountered in clinical hematology-oncology practice Selected Hematologic Diseases (online): provides an authoritative guide to therapy for principal diseases in consultative hematology The entire content is now online at AccessHemOnc.com. The online platform created for the third edition will be continually updated, including newly approved regimens.